208 related articles for article (PubMed ID: 26191949)
1. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study.
Oudin C; Auquier P; Bertrand Y; Contet A; Kanold J; Sirvent N; Thouvenin S; Tabone MD; Lutz P; Ducassou S; Plantaz D; Dalle JH; Gandemer V; Beliard S; Berbis J; Vercasson C; Barlogis V; Baruchel A; Leverger G; Michel G
Bone Marrow Transplant; 2015 Nov; 50(11):1438-44. PubMed ID: 26191949
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study.
Horwitz M; Auquier P; Barlogis V; Contet A; Poiree M; Kanold J; Bertrand Y; Plantaz D; Galambrun C; Berbis J; Villes V; Chastagner P; Sirvent N; Oudin C; Michel G
Br J Haematol; 2015 Feb; 168(4):518-25. PubMed ID: 25284463
[TBL] [Abstract][Full Text] [Related]
3. Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study.
Sisler IY; Koehler E; Koyama T; Domm JA; Ryan R; Levine JE; Pulsipher MA; Haut PR; Schultz KR; Taylor DS; Frangoul HA
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1620-7. PubMed ID: 19896086
[TBL] [Abstract][Full Text] [Related]
4. Adult testicular volume predicts spermatogenetic recovery after allogeneic HSCT in childhood and adolescence.
Wilhelmsson M; Vatanen A; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Pediatr Blood Cancer; 2014 Jun; 61(6):1094-100. PubMed ID: 24851267
[TBL] [Abstract][Full Text] [Related]
5. Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.
Kim JH; Stein A; Tsai N; Schultheiss TE; Palmer J; Liu A; Rosenthal J; Forman SJ; Wong JY
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):75-81. PubMed ID: 24725691
[TBL] [Abstract][Full Text] [Related]
6. Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation.
Bizzarri C; Pinto RM; Ciccone S; Brescia LP; Locatelli F; Cappa M
Pediatr Blood Cancer; 2015 Sep; 62(9):1650-5. PubMed ID: 26017459
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
[TBL] [Abstract][Full Text] [Related]
9. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
10. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
Chen YB; Coughlin E; Kennedy KF; Alyea EP; Armand P; Attar EC; Ballen KK; Cutler C; Dey BR; Koreth J; McAfee SL; Spitzer TR; Antin JH; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2013 Jun; 19(6):981-7. PubMed ID: 23562738
[TBL] [Abstract][Full Text] [Related]
11. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.
Lee JW; Kang HJ; Kim S; Lee SH; Yu KS; Kim NH; Jang MK; Kim H; Song SH; Park JD; Park KD; Shin HY; Jang IJ; Ahn HS
Biol Blood Marrow Transplant; 2015 Jan; 21(1):190-5. PubMed ID: 25255163
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia.
Oudin C; Simeoni MC; Sirvent N; Contet A; Begu-Le Coroller A; Bordigoni P; Curtillet C; Poirée M; Thuret I; Play B; Massot MC; Chastagner P; Chambost H; Auquier P; Michel G
Blood; 2011 Apr; 117(17):4442-8. PubMed ID: 21278355
[TBL] [Abstract][Full Text] [Related]
13. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
Fu H; Xu L; Liu D; Liu K; Zhang X; Chen H; Chen Y; Han W; Wang Y; Wang J; Wang F; Huang X
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1176-82. PubMed ID: 24747336
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study.
Saultier P; Auquier P; Bertrand Y; Vercasson C; Oudin C; Contet A; Plantaz D; Poirée M; Ducassou S; Kanold J; Tabone MD; Dalle JH; Lutz P; Gandemer V; Sirvent N; Thouvenin S; Berbis J; Chambost H; Baruchel A; Leverger G; Michel G
Haematologica; 2016 Dec; 101(12):1603-1610. PubMed ID: 27515247
[TBL] [Abstract][Full Text] [Related]
16. Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.
Chemnitz JM; von Lilienfeld-Toal M; Holtick U; Theurich S; Shimabukuro-Vornhagen A; Krause A; Brossart P; Hallek M; Scheid C
Ann Hematol; 2012 Jan; 91(1):47-55. PubMed ID: 21584670
[TBL] [Abstract][Full Text] [Related]
17. Treosulphan-based radiation-free myeloablative conditioning for allogeneic transplant in infant acute lymphoblastic leukaemia.
Corker E; Astwood E; Williams J; Vora A
Br J Haematol; 2012 Oct; 159(1):104-6. PubMed ID: 22804487
[No Abstract] [Full Text] [Related]
18. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang KY; Butker E; Khan MK; Haight AE; Chen Z; Esiashvili N
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):349-59. PubMed ID: 26853343
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
Bunin N; Aplenc R; Kamani N; Shaw K; Cnaan A; Simms S
Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]